Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution.

Autor: Kellner JN; Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Delemarre EM; Laboratory of Translational Immunology, University Medical Center Utrecht, Heidelberglaan, CX Utrecht, The Netherlands., Yvon E; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nierkens S; Laboratory of Translational Immunology, University Medical Center Utrecht, Heidelberglaan, CX Utrecht, The Netherlands., Boelens JJ; Department of Pediatrics, Stem Cell Transplant and Cellular Therapies, Memorial Sloan Kettering Cancer Center, New York, NY, USA., McNiece I; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Olson A; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nieto Y; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ciurea S; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Popat U; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ahmed S; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Champlin R; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ramos J; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nishimoto M; Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ma H; Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ke Z; Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Thall P; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Khoury JD; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Negrin R; Division of Blood and Marrow Transplantation, Stanford University, Palo Alto, CA, USA., Andersson B; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Parmar S; Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publikováno v: Oncotarget [Oncotarget] 2018 Nov 02; Vol. 9 (86), pp. 35611-35622. Date of Electronic Publication: 2018 Nov 02 (Print Publication: 2018).

Gene Modification of Human Natural Killer Cells Using a Retroviral Vector.

Autor: Kellner JN; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., P14.2920, Unit #065, Houston, TX, 77030, USA., Cruz CR; Program for Cell Enhancement and Technologies for Immunotherapy, The Sheikh Zayed Institute for Pediatric Surgical Innovation, the Center for Cancer and Immunology Research, Children's National Health System, Washington, DC, 20052, USA.; Departments of Pediatrics and Microbiology, Immunology and Tropical Medicine, The George Washington University, Washington, DC, 20052, USA., Bollard CM; Program for Cell Enhancement and Technologies for Immunotherapy, The Sheikh Zayed Institute for Pediatric Surgical Innovation, the Center for Cancer and Immunology Research, Children's National Health System, Washington, DC, 20052, USA.; Departments of Pediatrics and Microbiology, Immunology and Tropical Medicine, The George Washington University, Washington, DC, 20052, USA., Yvon ES; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., P14.2920, Unit #065, Houston, TX, 77030, USA. ESYvon@mdanderson.org.

Publikováno v: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2016; Vol. 1441, pp. 203-13.

Synergistic effects of ATP and RNA binding to human DEAD-box protein DDX1.

Autor: Kellner JN; Department of Biomolecular Mechanisms, Max-Planck-Institute for Medical Research, Jahnstrasse 29, 69120 Heidelberg, Germany., Reinstein J; Department of Biomolecular Mechanisms, Max-Planck-Institute for Medical Research, Jahnstrasse 29, 69120 Heidelberg, Germany., Meinhart A; Department of Biomolecular Mechanisms, Max-Planck-Institute for Medical Research, Jahnstrasse 29, 69120 Heidelberg, Germany anton.meinhart@mpimf-heidelberg.mpg.de.

Publikováno v: Nucleic acids research [Nucleic Acids Res] 2015 Mar 11; Vol. 43 (5), pp. 2813-28. Date of Electronic Publication: 2015 Feb 17.

Coupling of oligomerization and nucleotide binding in the AAA+ chaperone ClpB.

Autor: Werbeck ND; Department of Biomolecular Mechanisms, Max Planck Institute for Medical Research, Jahnstrasse 29, 69120 Heidelberg, Germany., Zeymer C, Kellner JN, Reinstein J

Publikováno v: Biochemistry [Biochemistry] 2011 Feb 08; Vol. 50 (5), pp. 899-909. Date of Electronic Publication: 2011 Jan 10.